Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 2025-12-02 04:01
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study 2025-11-06 21:30
OSR Holdings Provides Transparency Update on Equity Financing Instruments 2025-08-01 00:45
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure 2025-07-31 04:10
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology 2025-07-24 19:30
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company 2025-07-15 19:30
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics 2025-05-02 19:30
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology 2025-04-09 19:54
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies 2025-04-03 19:30
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma 2025-03-26 19:16
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer 2025-03-25 19:00
1